Fryirs B, Dawson M, Mather L E
Department of Anaesthesia and Pain Management, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW, Australia.
J Chromatogr B Biomed Sci Appl. 1997 May 23;693(1):51-7. doi: 10.1016/s0378-4347(97)00049-2.
A sensitive method was devised to determine morphine plasma concentrations by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM) with nalorphine as the internal standard. This method was rugged, reliable, selective and sensitive and was used to determine the morphine content of over 2000 samples. Sample preparation involved extraction of basified sample using n-butyl chloride-chloroform (5:1) and evaporation of the extract to dryness. The residue was derivatised with pentafluoropropionic anhydride, evaporated to dryness, reconstituted in 40 microl toluene and injected onto the GC-MS. For a sample size of 1 ml, the limit of quantitation was 0.75 ng/ml (S/N ratio 10:1) and the estimated limit of detection was calculated to be 0.2 ng/ml (S/N ratio 3:1), expressed as morphine base. Precision (n=5) was 4.9% at 0.75 ng/ml, 6.8% at 1.5 ng/ml, 3.0% at 37.5 ng/ml and 2.3% at 150 ng/ml. Standard curves for the range of 0-750 ng/ml morphine in plasma were linear with all r2 values greater than 0.99. No interfering peaks were seen for either morphine or internal standard in the blank samples. The method is suitable for pharmacokinetic studies after subclinical doses of morphine where it has been used to study morphine plasma concentrations for 6 h after a dose of only 2 mg.
设计了一种灵敏的方法,通过气相色谱-质谱联用仪(GC-MS),采用选择离子监测(SIM)模式,以烯丙吗啡作为内标来测定血浆中吗啡的浓度。该方法耐用、可靠、具有选择性且灵敏,已用于测定2000多个样本中的吗啡含量。样品制备包括用正丁基氯-氯仿(5:1)提取碱化后的样品,并将提取物蒸发至干。残渣用五氟丙酸酐衍生化,蒸发至干,用40微升甲苯复溶后注入GC-MS。对于1毫升的样本量,定量限为0.75纳克/毫升(信噪比10:1),估计检测限经计算为0.2纳克/毫升(信噪比3:1),以吗啡碱表示。精密度(n = 5)在0.75纳克/毫升时为4.9%,在1.5纳克/毫升时为6.8%,在37.5纳克/毫升时为3.0%,在150纳克/毫升时为2.3%。血浆中吗啡浓度在0 - 750纳克/毫升范围内的标准曲线呈线性,所有r2值均大于0.99。空白样本中未观察到吗啡或内标的干扰峰。该方法适用于亚临床剂量吗啡后的药代动力学研究,在此研究中,仅给予2毫克剂量后,它已用于研究长达6小时的吗啡血浆浓度。